Author:
Mett H.,Oberkirch I.,Schacher B.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference18 articles.
1. Bayer, A. S., Peters, J., Parr, T. R., Chan, L., Hancock, R. E. W. Role of β-lactamase in in vivo development of ceftazidime resistance in experimentalPseudomonas aeruginosa endocarditis. Antimicrobial Agents and Chemotherapy 1987, 31: 253–258.
2. Mett, H., Rosta, S., Schacher, B. Contribution of outer membrane permeability and of β-lactamases to β-lactam resistance. inPseudomonas maltophilia. In: Actor, P., Daneo-Moore, L., Higgins, M. L., Salton, M. R. J., Shockman, G. D. (ed.): Antibiotic inhibition of bacterial cell surface assembly and function. American Society for Microbiology, Washington, DC, 1987, p. 443–449.
3. Mett, H., Rosta, S., Schacher, B., Frei, R. Outer membrane permeability and β-lactamase content inPseudomonas maltophilia clinical isolates and laboratory mutants. Reviews of Infectious Diseases 1988, 10: 765–769.
4. Vu, H., Nikaido, H. Role of β-lactam hydrolysis in the mechanism of resistance of a β-lactamase-constitutiveEnterobacter cloacae strain to expanded-spectrum β-lactams. Antimicrobial Agents and Chemotherapy 1985, 27: 393–398.
5. Cullmann, W., Buescher, K. H., Dick, W. Selection and properties ofPseudomonas aeruginosa variants resistant to β-lactam antibiotics. European Journal of Clinical Microbiology 1987, 6: 467–473.